Association analysis of the 5-HT6 receptor polymorphism C267T with depression in patients with Alzheimer's disease

被引:24
作者
Liu, HC [1 ]
Hong, CJ
Liu, CY
Lin, KN
Tsai, SJ
Liu, TY
Chi, CW
Wang, PN
机构
[1] Taipei Vet Gen Hosp, Inst Neurol, Taipei, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan
[3] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan
[4] Chang Gung Univ Sch Med, Dept Psychiat, Taoyuan, Taiwan
[5] Chang Gung Mem Hosp, Taoyuan, Taiwan
[6] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan
关键词
Alzheimer's disease; depression; polymorphism; serotonin receptor 6 gene;
D O I
10.1046/j.1440-1819.2001.00886.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A significant increase of 267C allele of the 5-HT6 receptor gene has been reported in patients with Alzheimer's disease (AD). Because a deficit in serotonergic neurotransmission is involved in major depression, we tried to find out whether 267C allele is associated with depressive disorders in AD. A psychiatrist interviewed all AD patients and their caregivers fur evidence of depression using a Chinese version of the Standard Clinical Interview for DSM-III-R. The difference in the 5-HT6 genotype or allele distributions between the AD patients with depressive disorders (n=25) and those without (n=120) was not significant.
引用
收藏
页码:427 / 429
页数:3
相关论文
共 11 条
[1]  
BENTLEY JC, 1997, J PSYCHOPHARMACOL, V11, pA64
[2]   Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system [J].
Gerard, C ;
Martres, MP ;
Lefevre, K ;
Miquel, MC ;
Verge, D ;
Lanfumey, L ;
Doucet, E ;
Hamon, M ;
ElMestikawy, S .
BRAIN RESEARCH, 1997, 746 (1-2) :207-219
[3]   A RATING SCALE FOR DEPRESSION [J].
HAMILTON, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1960, 23 (01) :56-62
[4]  
Hong CJ, 1999, AM J MED GENET, V88, P601, DOI 10.1002/(SICI)1096-8628(19991215)88:6<601::AID-AJMG4>3.3.CO
[5]  
2-T
[6]   Depressive disorders in Chinese patients with Alzheimer's disease [J].
Liu, CY ;
Fuh, JL ;
Teng, EL ;
Wang, SJ ;
Wang, PN ;
Yang, YY ;
Liu, HC .
ACTA PSYCHIATRICA SCANDINAVICA, 1999, 100 (06) :451-455
[7]  
MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
[8]  
Meltzer CC, 1998, NEUROPSYCHOPHARMACOL, V18, P407
[9]  
Meneses A, 1998, REV NEUROSCIENCE, V9, P275
[10]  
SPITZER RL, 1985, STRUCTURAL CLIN INTE